KLF6mRNA expression in primary hepatocellular carcinoma

Abstract

To investigate the expression of KLF6mRNA in primary hepatocellular carcinoma (HCC), nomal liver tissues and the tissues adjacent to the cancers, reverse-transcription polymerase chain reaction (RT-PCR) was employed to investigate the expression of the KLF6 gene in HCC, the corresponding adjacent non-cancerous tissues and normal liver tissue. Our results showed that an amplified fragment of 127 bp DNA was detected in 18 of 19 (94.7%) adjacent non-cancerous tissues and normal liver tissue, and in 12 (85.7%) of 11 HCC. There were no significant differences in the levels of KLF6 mRNA between normal liver and liver tumors (P>0.05). It is concluded that KLF6 mRNA is generally expressed in HCC.

Keywords

Kruppel-like factor 6 (KLF6) / hepatocellular carcinoma (HCC) reverse-transcription polymerase chain reaction (RT-PCR)

References

[1] ZhangX, XuH J, MurakamiY, et al. . Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res, 1994, 54: 1177-1177

[2] LinY W, SheuJ C, LiuL Y, et al. . Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer, 1999, 35: 1730-1730

[3] NgI O, SrivastavaG, ChungL P, et al. . Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer, 1991, 71: 30-30

[4] VautierG, BomfordA B, PortmannB C, et al. . p53 mutations in British patients with hepatocellular carcinoma: clustering in genetic hemochromatosis. Gatroenterology, 1999, 117: 151-151

[5] GerbesA L, CaselmannW H. Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins. J Hepatol, 1993, 19: 312-312

[6] RashidA, WangJ S, QianG S, et al. . Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 1q and p53 gene mutation. Br J Cancer, 1999, 80: 59-59

[7] YumotoY, HanafusaT, HadaH, et al. . Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol, 1995, 10: 179-179

[8] LeonM, KewM C. Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks. Anticancer Res, 1995, 15: 859-859

[9] StorkP, LodaM, BosariS, et al. . Detection of K-ras mutation in pancreatic neoplasm by nonisotopic mismatched polymerase chain reaction. Oncogene, 1991, 6: 857-857

[10] RatziuV, LalazarA, WongL, et al. . Zf9, A Kruppel-like transcription factor up-regulatedin vivo during early hepatic fibrosis. Proc Natl Acad Sci USA, 1998, 95: 9500-9500

[11] KoritschonerN P, BoccoJ L, Panzetta-DutariG M, et al. . A Novel Human Zinc Finger Protein That Interacts with the Core Promoter Element of a TATA Box-less gene. J Biol Chem, 1997, 272: 9573-9573

[12] SuzukiT, YamamotoT, KurabayashiM, et al. . Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter. J Biochem, 1998, 121: 389-389

[13] BiekerJ J. Kruppel-like Factors: Three Fingers in Many Pies. J Biol Chem, 2001, 276: 34355-34355

[14] KimY, RatziuV, ChoiS G, et al. . Transcriptional activation of transforming growth factor betal and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. J Biol Chem, 1998, 273: 33750-33750

[15] KojimaS, HayashiS, ShimokadoK, et al. . Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF- 1 in vascular endothelial cells. Blood, 2000, 95: 1309-1309

[16] NarlaG, HeathK E, ReevesH L, et al. . KLF6, A Candidate Tumor Suppressor Gene Mutated in Prostate Cancer. Science, 2001, 294: 2563-2563

[17] Narla G, Heath K E, Reeves H Let al. KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer Supplementary material is available on science online at www. sciencemag. org/cgi/content/full294/5551/2563/DC1